(2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide

C114H143FN18O13S4 — CID 169431520

IUPAC(2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide
SMILESCC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cc(=O)n(C)c3ccccc23)cs1)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cc(=O)n(C)c3ccccc23)cs1)C1CCOCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc(F)c3ccccc23)cs1)C1CCC(C)(O)CC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cnn3ccccc23)cs1)C1CCOCC1
InChIInChI=1S/C30H37FN4O3S.C30H38N4O3S.C29H36N4O4S.C25H32N6O3S/c1-18(32-3)27(36)34-26(19-12-14-30(2,38)15-13-19)29(37)35-16-6-9-25(35)28-33-24(17-39-28)22-10-11-23(31)21-8-5-4-7-20(21)22;1-4-19(2)28(36)32-27(20-11-6-5-7-12-20)30(37)34-16-10-15-25(34)29-31-23(18-38-29)22-17-26(35)33(3)24-14-9-8-13-21(22)24;1-4-18(2)27(35)31-26(19-11-14-37-15-12-19)29(36)33-13-7-10-24(33)28-30-22(17-38-28)21-16-25(34)32(3)23-9-6-5-8-20(21)23;1-16(26-2)23(32)29-22(17-8-12-34-13-9-17)25(33)30-10-5-7-21(30)24-28-19(15-35-24)18-14-27-31-11-4-3-6-20(18)31/h4-5,7-8,10-11,17-19,25-26,32,38H,6,9,12-16H2,1-3H3,(H,34,36);8-9,13-14,17-20,25,27H,4-7,10-12,15-16H2,1-3H3,(H,32,36);5-6,8-9,16-19,24,26H,4,7,10-15H2,1-3H3,(H,31,35);3-4,6,11,14-17,21-22,26H,5,7-10,12-13H2,1-2H3,(H,29,32)/t18-,19?,25-,26-,30?;19-,25+,27+;18-,24+,26+;16-,21-,22-/m0110/s1
InChIKeyYADBTNZLGAUOIF-PCYRDCGESA-N
MW2120.78 g/mol
LogP17.16
Rot. Bonds28

About (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide

(2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide (PubChem CID 169431520) has the molecular formula C114H143FN18O13S4 and a molecular weight of 2120.78 g/mol. Its IUPAC name is (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide.

Molecular Properties

Compound Name(2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide
PubChem CID169431520
Molecular FormulaC114H143FN18O13S4
Molecular Weight2120.78 g/mol
Exact Mass2118.99
IUPAC Name(2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide
SMILESCC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cc(=O)n(C)c3ccccc23)cs1)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cc(=O)n(C)c3ccccc23)cs1)C1CCOCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc(F)c3ccccc23)cs1)C1CCC(C)(O)CC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cnn3ccccc23)cs1)C1CCOCC1
InChIInChI=1S/C30H37FN4O3S.C30H38N4O3S.C29H36N4O4S.C25H32N6O3S/c1-18(32-3)27(36)34-26(19-12-14-30(2,38)15-13-19)29(37)35-16-6-9-25(35)28-33-24(17-39-28)22-10-11-23(31)21-8-5-4-7-20(21)22;1-4-19(2)28(36)32-27(20-11-6-5-7-12-20)30(37)34-16-10-15-25(34)29-31-23(18-38-29)22-17-26(35)33(3)24-14-9-8-13-21(22)24;1-4-18(2)27(35)31-26(19-11-14-37-15-12-19)29(36)33-13-7-10-24(33)28-30-22(17-38-28)21-16-25(34)32(3)23-9-6-5-8-20(21)23;1-16(26-2)23(32)29-22(17-8-12-34-13-9-17)25(33)30-10-5-7-21(30)24-28-19(15-35-24)18-14-27-31-11-4-3-6-20(18)31/h4-5,7-8,10-11,17-19,25-26,32,38H,6,9,12-16H2,1-3H3,(H,34,36);8-9,13-14,17-20,25,27H,4-7,10-12,15-16H2,1-3H3,(H,32,36);5-6,8-9,16-19,24,26H,4,7,10-15H2,1-3H3,(H,31,35);3-4,6,11,14-17,21-22,26H,5,7-10,12-13H2,1-2H3,(H,29,32)/t18-,19?,25-,26-,30?;19-,25+,27+;18-,24+,26+;16-,21-,22-/m0110/s1
InChIKeyYADBTNZLGAUOIF-PCYRDCGESA-N
XLogP17.16
TPSA373.25 Ų
H-Bond Donors7
H-Bond Acceptors27
Rotatable Bonds28
Heavy Atoms150
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002120.78
LogP ≤ 517.16
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1027

Analyze (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide?
The IUPAC name of (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide (CID 169431520) is (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide.
What is the SMILES notation for (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide?
The canonical SMILES for (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide is CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cc(=O)n(C)c3ccccc23)cs1)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cc(=O)n(C)c3ccccc23)cs1)C1CCOCC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc(F)c3ccccc23)cs1)C1CCC(C)(O)CC1.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2cnn3ccccc23)cs1)C1CCOCC1.
What is the InChIKey of (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide?
The InChIKey is YADBTNZLGAUOIF-PCYRDCGESA-N. The full InChI is InChI=1S/C30H37FN4O3S.C30H38N4O3S.C29H36N4O4S.C25H32N6O3S/c1-18(32-3)27(36)34-26(19-12-14-30(2,38)15-13-19)29(37)35-16-6-9-25(35)28-33-24(17-39-28)22-10-11-23(31)21-8-5-4-7-20(21)22;1-4-19(2)28(36)32-27(20-11-6-5-7-12-20)30(37)34-16-10-15-25(34)29-31-23(18-38-29)22-17-26(35)33(3)24-14-9-8-13-21(22)24;1-4-18(2)27(35)31-26(19-11-14-37-15-12-19)29(36)33-13-7-10-24(33)28-30-22(17-38-28)21-16-25(34)32(3)23-9-6-5-8-20(21)23;1-16(26-2)23(32)29-22(17-8-12-34-13-9-17)25(33)30-10-5-7-21(30)24-28-19(15-35-24)18-14-27-31-11-4-3-6-20(18)31/h4-5,7-8,10-11,17-19,25-26,32,38H,6,9,12-16H2,1-3H3,(H,34,36);8-9,13-14,17-20,25,27H,4-7,10-12,15-16H2,1-3H3,(H,32,36);5-6,8-9,16-19,24,26H,4,7,10-15H2,1-3H3,(H,31,35);3-4,6,11,14-17,21-22,26H,5,7-10,12-13H2,1-2H3,(H,29,32)/t18-,19?,25-,26-,30?;19-,25+,27+;18-,24+,26+;16-,21-,22-/m0110/s1.
What are the key properties of (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide?
(2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide has a molecular weight of 2120.78 g/mol, XLogP of 17.16, 28 rotatable bonds, 7 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylbutanamide;(2S)-N-[(1S)-2-[(2S)-2-[4-(4-fluoronaphthalen-1-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(4-hydroxy-4-methylcyclohexyl)-2-oxoethyl]-2-(methylamino)propanamide;(2S)-2-(methylamino)-N-[(1S)-1-(oxan-4-yl)-2-oxo-2-[(2S)-2-(4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]ethyl]propanamide;(2R)-2-methyl-N-[(1S)-2-[(2S)-2-[4-(1-methyl-2-oxoquinolin-4-yl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]butanamide is sourced from PubChem (CID 169431520), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).